Mini Nicotine
NDC 17856-1241, Nicotine Polacrilex, lozenge, from ATLANTIC BIOLOGICALS CORP..
- Product NDC
- 17856-1241
- Status
- Listed
- Labeler
- ATLANTIC BIOLOGICALS CORP.
- Dosage form
- LOZENGE
- Route
- ORAL
- Product type
- HUMAN OTC DRUG
- Marketing category
- ANDA
- Application
- ANDA207868
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/17856-1241 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- NICOTINE4 mg/1
Pharmacologic classes
Cholinergic Nicotinic Agonist [EPC]; Nicotine [CS]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 17856-1241-1 | 17856124101 | 50 POUCH in 1 BOX (17856-1241-1) / 1 LOZENGE in 1 POUCH (17856-1241-2) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.
Use it
Look up 17856-1241 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/17856-1241 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 17856-1241. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.